The Attitudes and Beliefs of Oncology Nurse Practitioners Regarding Direct-to-Consumer Advertising of Prescription Medications
- 1 July 2004
- journal article
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 31 (4) , 777-83
- https://doi.org/10.1188/04.onf.777-783
Abstract
To obtain information about the knowledge and attitudes of oncology nurse practitioners (ONPs) concerning the effect of direct-to-consumer (DTC) advertising of prescription medications on prescribing patterns. Exploratory survey. Oncology Nursing Society Nurse Practitioner Special Interest Group members in the United States. 221 of 376 ONPs completed the survey (58%). Researcher-developed 12-question postal survey. Knowledge and attitudes of ONPs on DTC advertising effects on prescribing patterns. The findings were similar to those of previous studies of physicians regarding the number of visits when patients requested DTC-advertised medications. Major differences were the positive attitudes of ONPs toward potentially longer patient visits to explain and educate patients regarding medication requests based on DTC advertising and smaller percentages of ONPs who felt "pressured" to prescribe requested medications. ONPs have mixed opinions regarding the practice of DTC advertising but do not believe that they are influenced heavily by advertising with regard to prescriptive practices. ONPs consider patient encounters for education purposes as appropriate and include information about requested DTC-advertised medications in their approach to patient care. This is an exploratory survey of a specialty group of ONPs. More research is needed to further explore the practice of DTC advertising and potential influences on the prescribing patterns of ONPs. DTC advertising of prescription medications is increasing; ONPs need to increase their knowledge base about the potential for influences of prescriptive practices.Keywords
This publication has 20 references indexed in Scilit:
- Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer BewareJournal of Clinical Oncology, 2003
- Physician DiscontentJAMA, 2003
- Direct-to-Consumer Advertising and Shared Liability for Pharmaceutical ManufacturersPublished by American Medical Association (AMA) ,2003
- Direct-to-Consumer Promotion of Prescription DrugsPharmacoEconomics, 2001
- Direct-to-Consumer Advertising of Prescription Drugs: Implications for the Patient-Physician RelationshipJAMA, 2000
- Challenges in Regulating Direct-to-Consumer AdvertisingJAMA, 2000
- The Rise of Direct-to-Consumer Advertising of Prescription Drugs in the United StatesJAMA, 2000
- Direct-to-consumer advertising of prescription drugsWestern Journal of Medicine, 2000
- Direct-to-Consumer Prescription Drug Advertising Builds Bridges Between Patients and PhysiciansJAMA, 1999
- Direct-to-consumer promotion: an industry perspective.Clinical Therapeutics, 1998